GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Creo Medical Group PLC (LSE:CREO) » Definitions » Liabilities-to-Assets

Creo Medical Group (LSE:CREO) Liabilities-to-Assets : 0.22 (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Creo Medical Group Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Creo Medical Group's Total Liabilities for the quarter that ended in Dec. 2023 was £16.80 Mil. Creo Medical Group's Total Assets for the quarter that ended in Dec. 2023 was £76.60 Mil. Therefore, Creo Medical Group's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2023 was 0.22.


Creo Medical Group Liabilities-to-Assets Historical Data

The historical data trend for Creo Medical Group's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creo Medical Group Liabilities-to-Assets Chart

Creo Medical Group Annual Data
Trend Feb14 Feb15 Feb16 Jun17 Dec19 Dec20 Dec21 Dec22 Dec23
Liabilities-to-Assets
Get a 7-Day Free Trial Premium Member Only 0.06 0.32 0.27 0.34 0.22

Creo Medical Group Semi-Annual Data
Feb14 Feb15 Feb16 Dec16 Jun17 Dec17 Jun18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.30 0.34 0.22 0.22

Competitive Comparison of Creo Medical Group's Liabilities-to-Assets

For the Medical Devices subindustry, Creo Medical Group's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Creo Medical Group's Liabilities-to-Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Creo Medical Group's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Creo Medical Group's Liabilities-to-Assets falls into.



Creo Medical Group Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Creo Medical Group's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Liabilities-to-Assets (A: Dec. 2023 )=Total Liabilities/Total Assets
=16.8/76.6
=0.22

Creo Medical Group's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2023 is calculated as

Liabilities-to-Assets (Q: Dec. 2023 )=Total Liabilities/Total Assets
=16.8/76.6
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Creo Medical Group  (LSE:CREO) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Creo Medical Group Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Creo Medical Group's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Creo Medical Group (LSE:CREO) Business Description

Traded in Other Exchanges
N/A
Address
Beaufort Park Way, Unit 2, Creo House, Beaufort Park, Chepstow, GBR, NP16 5UH
Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy.

Creo Medical Group (LSE:CREO) Headlines

No Headlines